US Patent Issued to BEIJING SCITECH-MQ PHARMACEUTICALS on Oct. 7 for "Acylamino bridged heterocyclic compound, and composition and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,060, issued on Oct. 7, was assigned to BEIJING SCITECH-MQ PHARMACEUTICALS Ltd. (Beijing).

"Acylamino bridged heterocyclic compound, and composition and application thereof" was invented by Qiang Zhang (Beijing), Yansheng Liu (Beijing), Xingfu Li (Beijing), Shaohua Zhang (Beijing) and Chenming Hu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an acylamino bridged heterocyclic compound of formula (I) or a pharmaceutically acceptable salt, an isomer, a solvate, a crystal, or a prodrug thereof, and a pharmaceutical composition comprising the compound, and an application of the compound or composition in drug preparation. The compoun...